Skip to main content
. 2022 Jan 25;10(2):255. doi: 10.3390/biomedicines10020255

Table 1.

Noninvasive biomarkers.

Indicator Type Biomarker References
Tissue damage Faecal haemoglobin [7,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51]
Inflammation Calprotectin [21,23,30,33,34,35,36,37,38,39,40,41,42]
Chitinase 3-like 1 [43,44,45,46,47,48,49,50,51]
Intercellular stability E-cadherin [53,54,55,56,57,58,59,60,61,62,63,64,65,66]
Metabolic M2-pyruvate kinase [38,69,70,71,72,73,74,75,76,77,78,79,80,81]
Volatile organic compounds [14,23,82,83,84,85,86,87,88,89,90,91,92,93,94]
Small metabolites [14,95,96,97,98,99,100]
Host genetics Genetic and/or epigenetic markers [102,103,104]
MicroRNA [14,105,106,107]
Gut microbiota Fusobacterium nucleatum [120,121,122,123,124,125,126]